One cancer drug turned down after many years of research, but the company plans an appeal. The FDA continues to ask for substantial documentation in the hopes of better decision. Refusals don't help the cause when it comes to investors and the potential for continued research. Something...
This is an interesting opinion story from an individual that has a natural health site, which many have been criticized over the years as over talking what natural herbs and cures can product as far as results. This particular individual states only 1% of his entire site was related to cancer and...
This is one tough subject by all means. Yes, consumers want early access, but on the other hand if there’s not enough information regarding issues such as side effects, a drug could in fact hasten the process with individuals dying sooner, again studies are what is needed to be safe. ...
Posted to
The Medical Quack .... by Barbara Duck
on 07-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Cancer, FDA, clinical trials, Research, University of California
This article does a very good job in explaining the next wave in pharmaceuticals...everyone knows what the "Blockbuster Drug" is...but this was even a new term for me...the new model...and returning R and D back to the scientists...(per Garnier)...almost like what could be considered "baby...
CBS is doing a special report this week on drugs for cancer. This video has an interview with the Head of Oncology from the FDA and what their process is to approve drugs for cancer....and an interview with one of the Biotech companies who make the drugs explains that the US requires a whole new clinical...